AMSBIO Provides the Detachin™ Cell Detachment Solution

Detachin™ Cell Detachment Solution from AMSBIO is a high-performance alternative to Trypsin/EDTA for detaching adherent cells from in vitro growth vessels. Detachin™ provides rapid, gentle, and effective detachment of a wide variety of adherent cells, including primary cells, from all commercially available tissue culture plasticware.

Proven to provide a consistent, safe, and efficient method for cell detachment and dissociation, Detachin™ contains protease and collagenase activities in an isotonic, phosphate buffer solution with EDTA. It has been tested successfully on many different primary cells and cell lines, including: bone marrow cells, stem cells, fibroblasts, hepatocytes, mouse germ cells, keratinocytes, macrophages, chick embryo cells, neuronal cells, vascular endothelial cells, A-375, BHK, CHO, COS, D54, HEK293, HeLa, L-929, M-24, MG-63, MRC-5, NIH-3T3, NT-2 cells, U-251, Vero, Sf9 insect cells, and many others. 

Not only does Detachin™ Cell Detachment Solution offer improved cell viability compared to Trypsin, it also produces no mammalian or bacterial byproducts meaning there is no need to wash your detached cells. 
 

Offered in a range of convenient formats including 100 mL, 10 x 100 mL, and 6-PAC (6 x 50 mL) sizes and stable at 4C for 2 months, Detachin™ provides an economic solution to labs regularly tasked with cell detachment protocols.

For further information on Detachin™ Cell Detachment Solution please visit http://www.amsbio.com/detachin-cell-detachment-solution.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com. 

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.   

For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology. For further information please visit www.amsbio.com. 

Worldwide HQ 

AMS Biotechnology (AMSBIO)

184 Milton Park
Abingdon

Oxon OX14 4SE

UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com 
Web www.amsbio.com

 

North American HQ

 

AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033 
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com 
Web: www.amsbio.com